-
Primary care physicians often are confronted with patients presenting with either gross or microscopic hematuria. Either situation demands a clinical investigation.
-
FDA warning on topical anesthetics; antipsychotics increase sudden cardiac death; the step up vs step down debate; treating pain, fatigue, mood, and sleep in fibromyalgia; FDA Actions.
-
-
-
-
-
Nucleic acid tests (NAA) for the diagnosis of pulmonary tuberculosis (TB) have had FDA approval for more than a decade, but their use has been limited, at least in part because of a frequent lack of availability in local laboratories.
-
The Merck integrase inhibitor, raltegravir, was studied in two identical trials in different geographic locations to evaluate its safety and efficacy vs placebo in combination with optimized background therapy in patients infected with 3-drug class-resistant (3DCR) HIV-1.
-
At the 57th annual meeting of the Aamerican Society of Tropical Medicine and Hygiene in New Orleans, held from December 7-11, 2008, the CDC presented malaria and travel vaccine updates. Dr. Paul Arguin from the Domestic Malaria Unit presented "Malaria Update: Surveillance, Prevention, Treatment."
-
Preliminary data from this year's flu season indicates that another mismatch may be occurring between this year's vaccine and the predominant circulating strains of influenza A and influenza B viruses.
